Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIAISON Testosterone xt

K-Number: K201908 · 2020-10-15

Decision Date2020-10-15
Product CodeCDZ
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

LIAISON Testosterone xt is a medical device manufactured by DiaSorin, Inc.. It received FDA 510(k) clearance on 2020-10-15 under approval number K201908. The device is classified under product code CDZ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIAISON Testosterone xt?

LIAISON Testosterone xt is a medical device that received FDA 510(k) clearance on 2020-10-15. It is manufactured by DiaSorin, Inc.. The 510(k) number is K201908.

When was LIAISON Testosterone xt approved by the FDA?

LIAISON Testosterone xt received FDA 510(k) clearance on 2020-10-15, under approval number K201908.

What company makes LIAISON Testosterone xt?

LIAISON Testosterone xt is manufactured by DiaSorin, Inc..

What is the FDA product code for LIAISON Testosterone xt?

The FDA product code for LIAISON Testosterone xt is CDZ.

Other Devices by DiaSorin, Inc.

View all 41 devices →

Related Devices (Code: CDZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.